Supraphysiological doses of performance enhancing anabolic-androgenic steroids exert direct toxic effects on neuron-like cells

Frontiers in Cellular Neuroscience

Volumn , Issue APR, 2013, Pages

  Basile, John R ^a,b   Binmadi, Nada O ^a,c   Zhou, Hua ^a   Yang, Ying hua ^a   Paoli, Antonio ^d   Proia, Patrizia ^a,e  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

Anabolic androgenic steroids; Apoptosis; Neuritin; Neurotoxicity; Pc12

Indexed keywords

ANDROGEN RECEPTOR; CASPASE 3; HEAT SHOCK PROTEIN 90; MESSENGER RNA; METANDIENONE; METHYLTESTOSTERONE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEURITIN; NEUROTROPIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN SLICE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; IMMUNOFLUORESCENCE TEST; NERVE CELL NETWORK; NEURITE; NEUROTOXICITY; NONHUMAN; PC12 CELL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE CELL; WESTERN BLOTTING;

EID: 84876518098     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00069     Document Type: Article

References (54)

1. Arya R., Mallik M., Lakhotia S. C. (2007). Heat shock genes - integrating cell survival and death. J. Biosci. 32, 595-610.
2. Barone S., Jr., Das K. P., Lassiter T. L., White L. D. (2000). Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21, 15-36.
3. Basaria S. (2010). Androgen abuse in athletes: detection and consequences. J. Clin. Endocrinol. Metab. 95, 1533-1543.
4. Basile J. R., Castilho R. M., Williams V. P., Gutkind J. S. (2006). Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. PNAS 103, 9017- 9022.
5. Bishop S. C., Burlison J. A., Blagg B. S. (2007). Hsp90: a novel target for the disruption of multiple signaling cascades. Curr. Cancer Drug Targets 7, 369-388.
6. Caraci F., Pistara V., Corsaro A., Tomasello F., Giuffrida M. L., Sortino M. A., et al. (2011). Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. J. Neurosci. Res. 89, 592-600.
7. Carmo C. A., Goncalves A. L., Salvadori D. M., Maistro E. L. (2011). Nandrolone androgenic hormone presents genotoxic effects in different cells of mice. J. Appl. Toxicol.
8. Chan J. and Quik M. (1993). A role for the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC12 cells. Neuroscience 56, 441-451.
9. Chen H., Xia Y., Fang D., Hawke D., Lu Z. (2009). Caspase-10-mediated heat shock protein 90 beta cleavage promotes UVB irradiation-induced cell apoptosis. Mol. Cell Biol. 29, 3657-3664.
10. Chen Y., Sawyers C. L., Scher H. I. (2008). Targeting the androgen receptor pathway in prostate cancer. Curr. Opin. Pharmacol. 8, 440-448.
11. Craig A. M. and Banker G. (1994). Neuronal polarity. Annu. Rev. Neurosci. 17, 267-310.
12. Crumpton T., Atkins D. S., Zawia N. H., Barone S., Jr. (2001). Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology 22, 49-62.
13. D'Ascenzo S., Millimaggi D., Di Massimo C., Saccani-Jotti G., Botre F., Carta G., et al. (2007). Detrimental effects of anabolic steroids on human endothelial cells. Toxicol. Lett. 169, 129-136.
14. Das K. P. and Barone S., Jr. (1999). Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? Toxicol. Appl. Pharmacol. 160, 217-230.
15. de Graaf E. L., Vermeij W. P., de Waard M. C., Rijksen Y., van der Pluijm I., Hoogenraad C. C., et al. (2013). Spatio-temporal analysis of molecular determinants of neuronal degeneration in the aging mouse cerebellum. Mol. Cell Proteomics.
16. do Carmo C. A., Goncalves A. L., Salvadori D. M., Maistro E. L. (2012). Nandrolone androgenic hormone presents genotoxic effects in different cells of mice. J. Appl. Toxicol. 32, 810-814.
17. Duranti G., La Rosa P., Dimauro I., Wannenes F., Bonini S., Sabatini S., et al. (2011). Effects of salmeterol on skeletal muscle cells: metabolic and proapoptotic features. Med. Sci. Sports Exerc. 43, 2259-2273.
18. Fargo K. N., Alexander T. D., Tanzer L., Poletti A., Jones K. J. (2008). Androgen regulates neuritin mRNA levels in an in vivo model of steroid-enhanced peripheral nerve regeneration. J. Neurotrauma 25, 561-566.
19. Fujita K., Lazarovici P., Guroff G. (1989). Regulation of the differentiation of PC12 pheochromocytoma cells. Environ. Health Perspect. 80, 127-142.
20. Gehlhaus M., Schmitt N., Volk B., Meyer R. P. (2007). Antiepileptic drugs affect neuronal androgen signaling via a cytochrome P450-dependent pathway. J. Pharmacol. Exp. Ther. 322, 550-559.
21. Greene L. A. and Rein G. (1977). Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells. Brain Res. 129, 247-263.
22. Gruber A. J. and Pope H. G., Jr. (2000). Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother. Psychosom. 69, 19-26.
23. Hall R. C. and Chapman M. J. (2005). Psychiatric complications of anabolic steroid abuse. Psychosomatics 46, 285-290.
24. Haviv R., Lindenboim L., Li H., Yuan J., Stein R. (1997). Need for caspases in apoptosis of trophic factor-deprived PC12 cells. J. Neurosci. Res. 50, 69-80.
25. Heinlein C. A. and Chang C. (2002). The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol. 16, 2181-2187.
26. Imperlini E., Mancini A., Spaziani S., Martone D., Alfieri A., Gemei M., et al. (2010). Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Proteomics 10, 3165-3175.
27. Kanayama G., Boynes M., Hudson J. I., Field A. E., Pope H. G., Jr. (2007). Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 88, 156-162.
28. Karmarkar S. W., Bottum K. M., Krager S. L., Tischkau S. A. (2011). ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells. PLoS One 6, e23493.
29. Kouri E. M., Pope H. G., Jr., Katz D. L., Oliva P. (1995). Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin. J. Sport Med. 5, 223-228.
30. Kuhn C. M. (2002). Anabolic steroids. Recent Prog. Horm. Res. 57, 411-434.
31. Lein P., Gallagher P. J., Amodeo J., Howie H., Roth J. A. (2000). Manganese induces neurite outgrowth in PC12 cells via upregulation of alpha(v) integrins. Brain Res. 885, 220-230.
32. Lewis J., Devin A., Miller A., Lin Y., Rodriguez Y., Neckers L., et al. (2000). Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J. Biol. Chem. 275, 10519-10526.
33. Malarkey W. B., Strauss R. H., Leizman D. J., Liggett M., Demers L. M. (1991). Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am. J. Obstet. Gynecol. 165, 1385-1390.
34. Meyer R. P., Gehlhaus M., Schwab R., Burck C., Knoth R., Hagemeyer C. E. (2009). Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J. Neurochem. 109, 670-681.
35. Mooradian A. D., Morley J. E., Korenman S. G. (1987). Biological actions of androgens. Endocr. Rev. 8, 1-28.
36. Naeve G. S., Ramakrishnan M., Kramer R., Hevroni D., Citri Y., Theill L. E. (1997). Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. PNAS 94, 2648-2653.
37. Nguyen T. V., Yao M., Pike C. J. (2005). Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J. Neurochem. 94, 1639-1651.
38. Nguyen T. V., Yao M., Pike C. J. (2007). Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. Endocrinology 148, 2936-2943.
39. Oberlander J. G. and Henderson L. P. (2012). The Sturm und Drang of anabolic steroid use: angst, anxiety, and aggression. Trends Neurosci. 35, 382-392.
40. Orlando R., Caruso A., Molinaro G., Motolese M., Matrisciano F., Togna G., et al. (2007). Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures. Brain Res. 1165, 21-29.
41. Parran D. K., Barone S., Jr., Mundy W. R. (2003). Methylmercury decreases NGF-induced TrkA autophosphorylation and neurite outgrowth in PC12 cells. Brain Res. Dev. Brain Res. 141, 71-81.
42. Penatti C. A., Costine B. A., Porter D. M., Henderson L. P. (2009). Effects of chronic exposure to an anabolic androgenic steroid cocktail on alpha5-receptor-mediated GABAergic transmission and neural signaling in the forebrain of female mice. Neuroscience 161, 526-537.
43. Penatti C. A., Oberlander J. G., Davis M. C., Porter D. M., Henderson L. P. (2011). Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse. Neuropharmacology 61, 653-664.
44. Radio N. M. and Mundy W. R. (2008). Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29, 361-376.
45. Santamarina R. D., Besocke A. G., Romano L. M., Ioli P. L., Gonorazky S. E. (2008). Ischemic stroke related to anabolic abuse. Clin. Neuropharmacol. 31, 80-85.
46. Schiera G., Proia P., Alberti C., Mineo M., Savettieri G., Di Liegro I. (2007). Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles. J. Cell. Mol. Med. 11, 1384-1394.
47. Tang T. S., Slow E., Lupu V., Stavrovskaya I. G., Sugimori M., Llinas R., et al. (2005). Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. PNAS 102, 2602-2607.
48. Thiblin I., Lindquist O., Rajs J. (2000). Cause and manner of death among users of anabolic androgenic steroids. J. Forensic Sci. 45, 16-23.
49. Tirassa P., Thiblin I., Agren G., Vigneti E., Aloe L., Stenfors C. (1997). High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J. Neurosci. Res. 47, 198-207.
50. Trifunovic B., Norton G. R., Duffield M. J., Avraam P., Woodiwiss A. J. (1995). An androgenic steroid decreases left ventricular compliance in rats. Am. J. Physiol. 268, H1096-1105.
51. Ujike H., Takaki M., Kodama M., Kuroda S. (2002). Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann. N Y Acad. Sci. 965, 55-67.
52. Uzych L. (1992). Anabolic-androgenic steroids and psychiatric-related effects: a review. Can. J. Psychiatry 37, 23-28.
53. Varshney A. and Ehrlich B. E. (2003). Intracellular Ca2+ signaling and human disease: the hunt begins with Huntington's. Neuron 39, 195-197.
54. Vaudry D., Stork P. J., Lazarovici P., Eiden L. E. (2002). Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648-1649.